Return to Univera Employers News

Rx Update - Understanding The Biosimilar Landscape

As new biosimilars enter the market, increased competition brings down the price of the biosimilar and reference product. As biosimilars continue to grow in use, it is important to understand what they are and their impact in the market.

In our ongoing efforts to ensure access to high quality, affordable health care and reduce costs, Univera Healthcare leads the insurance industry in pursuing biosimilar drugs for our members and have been a national leader in biosimilar adoption since their inception.

To learn more about our approach to biosimilars? Read our blog, “Understanding the Biosimilar Landscape”.

Read “Understanding the Biosimilar Landscape”

 

 
 
RELATED NEWS:
2026 Large Group Product Updates And Reminders

Current Injectable GLP-1 Mail Order Prescriptions From Express Scripts® Pharmacy Transitioning To EnGuide Pharmacy

Updated Fully Insured And Minimum Premium Documentation For 2025 CAA Gag Clause Attestation

Prescription Drug Collection (RxDC) Report Submitted

Rite Aid Pharmacy Closures

CATEGORY:

Univera

Employer

Employer Specific

Small Business

Midsize & Large Business

Pharmacy

Rx

 

GDPR Notification Content